$0.1845
-0.0191-9.38%
VolitionRX Ltd (VNRX) Stock Price, Quote, News & History
VNRXAMEX
VolitionRx reports 112% revenue growth in H1 2026 while advancing its Nu.Q diagnostic platforms across sepsis and oncology markets.
You can purchase shares of VolitionRX (AMEX:VNRX) through any online brokerage.
Other companies in VolitionRX’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), Align Technology Inc (NASDAQ:ALGN) and The Cooper Companies Inc (NASDAQ:COO).
VolitionRX has a consensus price target of $50.57.
The stock price for VolitionRX (AMEX: VNRX) is $ last updated .
There are no upcoming dividends for VolitionRX.
VolitionRX does not have any upcoming earnings scheduled.
There is no upcoming split for VolitionRX.
VolitionRX is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the AMEX.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases...
